Discuss in detail the risk factors for the development of cancer.

Anurse recently administered filgrastim intravenously to a client who has cancer and is receiving cytotoxic chemotherapy. for which of the following data, discovered after the medication was administered, should the nurse consider filling an incident report? a. the client had chemotherapy 12 hr before the medication was administered. b. the nurse flushed the client’s iv line with d5w before and after the medication was administered. c. the client’s absolute neutrophil count was 2,500/mm^3 before the medication was administered. d. the medication vial sat at the room temperature for 2 hr before it was administered.

Name the bone/structure/process that fits the following description: a) a bone with a complex shape. b) found in the medullary cavity. c) a large, rough process. d) it is thin, like a plate. e) shaft of a long bone. f) a mature bone cell. g) a large, round, smooth process. h) it covers outer surface of bone. i) a shallow depression on surface of bone. j) a roughly cube-shaped bone. k) the covering of epiphysis. l) a very narrow ridge of bone. m) space between lamellae for an osteocyte. n) chamber within diaphysis o) also called wormian bone. p) it secretes new matrix. q) end of a long bone. r) a small, round hole. s) a matrix, arrangement in spongy bone. t) it is a chamber within a bone. u) a network allowing osteocytes to receive nutrients. v) one example is the patella. w) it houses artery, vein and nerve. x) almost flat, smooth surface of a bone. y) a narrow, pointed process.

Aperson has been born with a mutation that results in a deficiency in the production of mhc i by all of their cells. how might this deficiency affect a person immunologically?